- Category
- Medium (2024-25)
- Udyam number
- UDYAM-TN-24-0007318

About Nuray Chemicals Private Limited
Data last updated:
Nuray Chemicals Private Limited is a private limited company based in Thiruvallur, Tamil Nadu, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24110TN2012PTC086320. Its GSTIN is 33AAECN0289P1Z2 (Tamil Nadu).
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹23.84 Cr. It is led by directors including Shanmugam Muthusamy and Jaganathan Jayaseelan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Ground Floor Plot No.111 SIDCO Industrial Estate Kakkalur, Thiruvallur, Tamil Nadu, India – 602003.
As per the financials filed for FY 2025, the company reported a revenue of ₹122.27 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹7.32 Cr (net margin 6%) and EBITDA of ₹17.2 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 21% over five years.
The company has about 347 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nuray chemicals. As per MCA filings, the company has open charges of ₹13 Cr and satisfied charges of ₹58.25 Cr on record. Court records list 15 cases involving the company, including 3 filed by the company and 12 filed against it. The company has 1 deal on record (1 funding round), with disclosed funding of ₹23.83 Cr; the latest was in January 2013. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 2 smaller; the largest is Smruthi Organics Ltd with revenue of ₹126.1 Cr.
Nuray Chemicals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-24-0007318). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nuraychemicals.com.
Company details
Recognitions & Rankings of Nuray Chemicals
Contact details
Nuray Chemicals Private Limited's registered office is in Thiruvallur, Tamil Nadu. Its website is nuraychemicals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGround Floor Plot No.111 SIDCO Industrial Estate Kakkalur, Thiruvallur, Tamil Nadu, India – 602003
- IndustryPharma, API Manufacturers
To see the full contact details of Nuray Chemicals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Nuray Chemicals operates one associated brand: Nuray chemicals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients for global generic players. | nuraychemicals.com |
Business activity
The main business activity of Nuray Chemicals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nuray Chemicals Private Limited, buy the company report.
Financials of Nuray Chemicals Private Limited
FY 2024 filings availableNuray Chemicals Private Limited reported revenue of ₹122.27 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 16% growth in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.32 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nuray Chemicals Private Limited, buy the company report.
Board of directors of Nuray Chemicals Private Limited
Nuray Chemicals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayyavu Rajavel Also directs: Saimirra Innopharm Private Limited, Delvin Surgicals Private Limited, Tindivanam Pharma Park Association and 5 more | Alternate Director | 14 Jun 2012 | 14 Years 5 Months | Current |
| Shanmugam Muthusamy Also directs: Saimirra Innopharm Private Limited, Annamar Pharma LLP, Esjay Pharma Private Limited and 5 more | Director | 20 Jul 2016 | 10 Years 3 Months | Current |
| Jaganathan Jayaseelan Also directs: Durujaya Infrastructure LLP, Clan Laboratories Private Limited, Saimirra Innopharm Private Limited and 5 more | Director | 14 Jun 2012 | 14 Years 5 Months | Current |
| Ravi Kulandasamy | Director | 04 Mar 2020 | 6 Years 8 Months | Current |
Peer comparison
Nuray Chemicals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Smruthi Organics Ltd | ₹126.1 Cr (FY 2025) | -1.0% | Solapur, Maharashtra, India | |||
| Alcon Biosciences Private Limited | ₹125.22 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Quad Lifesciences Private Limited | ₹123.66 Cr (FY 2025) | 26.0% | Derabassi, Punjab, India | |||
| Roopa Industries Limited | ₹122.98 Cr (FY 2025) | 72.0% | Kurnool, A.P, Andhra Pradesh, India | |||
| Richter Themis Medicare (India) Private Limited | ₹122.69 Cr (FY 2025) | -13.0% | Valsad, Gujarat, India | |||
| Nuray Chemicals Private Limitedthis company | ₹122.27 Cr (FY 2025) | ₹7.32 Cr | 6% | 16.0% | 347 | Thiruvallur, Tamil Nadu, India |
| Glenfin Chemicals Private Limited | ₹121.15 Cr (FY 2023) | 21.0% | Thane, Maharashtra, India | |||
| Kimia Biosciences Limited | ₹120.24 Cr (FY 2025) | 13.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Nuray Chemicals Private Limited, buy the company report.
Auditor
Nuray Chemicals Private Limited is audited by Essveeyar for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Essveeyar | FY 2023 | 000808S |
Shareholding
The shareholding of Nuray Chemicals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nuray Chemicals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2023 | 100869760 | Others | ₹6 Cr | Open | |
| 29 Aug 2017 | 100118984 | Others | ₹7 Cr | Open | |
| 01 Oct 2021 | 100494984 | Others | ₹1.75 Cr | Satisfied | |
| 29 Aug 2017 | 100118980 | Others | ₹8.2 Cr | Satisfied | |
| 17 Jun 2015 | 10579371 | State Bank of India | ₹10 Cr | Satisfied |
To see the full charge records of Nuray Chemicals Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Nuray Chemicals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹23.83 Cr; the latest was in January 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2013 | Funding round | ₹23.83 Cr | Investors: Clan Laboratories Private Limited , 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nuray Chemicals Private Limited has 15 court cases on record: 3 filed by Nuray Chemicals, 12 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 12 | 0 |
| High courts | 3 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Assistant Commissioner of Income Tax and 1 other | Disposed |
| High Court, TAMIL NADU | Writ petition | Filed by the company against Assistant Commissioner of Income Tax and 1 other | Disposed |
| District court, Viluppuram, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Disposed |
| District court, Viluppuram, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Disposed |
| District court, Viluppuram, Tamil Nadu | Motor accident claim | Filed against the company by an individual | Disposed |
To see the full case history of Nuray Chemicals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Nuray Chemicals Private Limited was last rated by Crisil on 15 Jun 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Jun 2021 |
To see the full credit ratings and regulatory alerts of Nuray Chemicals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuray Chemicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nuray Chemicals Private Limited has a workforce of 347 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 347 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Nuray Chemicals Private Limited, buy the company report.
GST
Nuray Chemicals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECN0289P1Z2 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nuray Chemicals Private Limited, buy the company report.
Recent activity
Nuray Chemicals Private Limited has 7 board changes on record since 2012: 4 appointments and 3 cessations. The latest: Ganapathy Panchapakesan ceased to be Director on 04 Mar 2020.
12 earlier events are in the company report.
Frequently asked questions
Nuray Chemicals is an active private limited company based in Thiruvallur, Tamil Nadu, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 June 2012 (14+ years old) and is registered under CIN U24110TN2012PTC086320.
Nuray Chemicals has 4 current directors:
- Ayyavu Rajavel - Alternate Director
- Shanmugam Muthusamy - Director
- Jaganathan Jayaseelan - Director
- Ravi Kulandasamy - Director
The latest financial statements of Nuray Chemicals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Nuray Chemicals is 33AAECN0289P1Z2, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Nuray Chemicals is U24110TN2012PTC086320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuray Chemicals has 15 court cases on record: 3 filed by the company and 12 filed against it. Most are in the district courts.
Nuray Chemicals was incorporated on 14 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chennai.
Nuray Chemicals has 1 deal on record (1 funding round), with disclosed funding of ₹23.83 Cr; the latest was in January 2013.
The peers of Nuray Chemicals by revenue are Smruthi Organics Ltd, Alcon Biosciences Private Limited, Quad Lifesciences Private Limited, Roopa Industries Limited, Richter Themis Medicare (India) Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ganapathy Panchapakesan ceased to be Director on 04 Mar 2020. Ravi Kulandasamy was appointed as Director on 04 Mar 2020. Ayyavu Rajavel ceased to be Director on 20 Jul 2016. Nuray Chemicals has 7 board changes on record in total.
Yes, Nuray Chemicals is registered as a medium enterprise under Udyam registration (number: UDYAM-TN-24-0007318).

